SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (353)1/28/1999 12:59:00 PM
From: aknahow  Read Replies (1) | Respond to of 712
 
No, I was only looking at end sales. Up 24% vs up 35% in previous period. Yes, I am aware that as the base gets bigger the percentage growth gets smaller but I did not expect this yet.

BTW the issue you raise, is important for Centocor but not to which drug is might be gaining or pulling even farther ahead. of the other. I see the two drugs as direct competitors but others might have a better understanding.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News